We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Treatment of indolent cutaneous T‐cell lymphoma with hypofractionated radiation therapy in three cats.
- Authors
Chadsey, Laura E.; Cook, Matthew R.; Green, Eric E.; Jennings, Ryan N.; Moore, Peter F.; Vernau, William; Kisseberth, William C.; Diaz, Sandra F.
- Abstract
Another case series reported times up to 48 months with an average of 5.9 months to diagnosis.1 Smaller lesion size and decreased skin invasion earlier in the disease process may improve the success of RT and overall treatment outcomes. The advent of molecular clonality PCR assays (PARR) in cats now enables a definitive diagnosis of ICL, and the ability to more accurately investigate the efficacy of various therapies. B Background b - Feline indolent cutaneous T-cell lymphoma (ICL) is an uncommon neoplastic disease. Accurate and timely diagnosis of ICL is a major limiting factor in the treatment of CL.
- Subjects
CUTANEOUS T-cell lymphoma; LYMPHOPROLIFERATIVE disorders; RADIOTHERAPY; RITUXIMAB; CAT diseases; CATS; T-cell receptor genes
- Publication
Veterinary Dermatology, 2021, Vol 32, Issue 5, p515
- ISSN
0959-4493
- Publication type
Article
- DOI
10.1111/vde.13002